|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cardiology, Dartmouth Medical School, Lebanon, NH, USA
2 Surgery, Beth Israel Deaconess Med Ctr, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: michael.simons{at}dartmouth.edu.
Syndecan-4 is one of the principal heparan sulfate carrying protein on the cell surface. Unlike other members of syndecan family, syndecan mediates PIP2 dependent PKC-
activation and overexpression of syndecan-4 in vitro results in enhanced FGF2 signaling. The present study was designed to test functional effect of increased syndecan-4 expression in endothelial cells in transgenic mice. Several transgenic mice lines expressing syndecan-4 cDNA under control of human eNOS promoter were generated. Exogenous syndecan-4 was mainly expressed in the heart, brain, and lungs. In particular, the heart demonstrated the greatest increase in the ratio of transgenic to native syndecan-4 gene expression. Vessels from the eNOS-S4 mice demonstrated more pronounced vasodilation to FGF2 but not to VEGF-A165, SNP and A23187 compared to the wild type mice. In order to elucidate the mechanism of this effect, we measured nitric oxide (NO) release from primary cardiac endothelial cells isolated from transgenic or wild type adult mice. Cells from the eNOS-syndecan 4 transgenic mice had a significant increase in FGF2 and VEGF-A165 -induced NO release compared to endothelial cells from the wild type mice. However, the absolute magnitude of this increase was higher for FGF2 than VEGF-A165. In conclusion, enhanced syndecan 4 expression in mouse cardiac endothelial cells results in preferential augmentation of FGF2 but not VEGF-A165-induced NO release.
This article has been cited by other articles:
![]() |
M. Boodhwani, P. Voisine, M. Ruel, N. R. Sodha, J. Feng, S.-H. Xu, C. Bianchi, and F. W. Sellke Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koh, R. D. Mahan, and G. E. Davis Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling J. Cell Sci., April 1, 2008; 121(7): 989 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Lanahan, T. W. Chittenden, E. Mulvihill, K. Smith, S. Schwartz, and M. Simons Synectin-dependent gene expression in endothelial cells Physiol Genomics, November 21, 2006; 27(3): 380 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tkachenko, J. M. Rhodes, and M. Simons Syndecans: New Kids on the Signaling Block Circ. Res., March 18, 2005; 96(5): 488 - 500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |